コンテンツぞスキップ
Merck

176870

Angiotensinogen, Human Plasma

Native angiotensinogen from human plasma that is cleaved by renin to generate angiotensin I. It is a part of the renin-angiotensin system that regulates blood pressure and fluid balance.

別名:

Angiotensinogen, Human Plasma, AGT, AGT Angiotensinogen, Human Plasma Serpin A8 Hypertensinogen, Renin Substrate, Hypertensinogen, Serpin A8

ログむンで組織・契玄䟡栌をご芧ください。

サむズを遞択しおください

衚瀺を倉曎する

この商品に぀いお

CAS番号:
UNSPSC Code:
12352202
NACRES:
NA.77
MDL number:
Form:
solid
Assay:
≥95% (SDS-PAGE)
テクニカルサヌビス
お困りのこずがあれば、経隓豊富なテクニカルサヌビスチヌムがお客様をサポヌトしたす。
お手䌝いしたす


Quality Segment

assay

≥95% (SDS-PAGE)

form

solid

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze

technique(s)

cell based assay: suitable

solubility

water: soluble

NCBI accession no.

UniProt accession no.

shipped in

ambient

storage temp.

−20°C

Gene Information

human ... AGT(183)

General description

Research area: CELL SIGNALING

Native angiotensinogen from human plasma is an α2-globulin present in plasma at about 7 mg/100 ml.

Angiotensinogen serves as a precursor for the production of angiotensin. In humans, angiotensinogen is composed of 485 amino acids. It is primarily synthesized and continuously secreted by the liver.

Application

Angiotensinogen has been used for the detection and analysis of the complexes formed between angiotensinogen and proform of eosinophil major basic protein (ProMBP) in both serum and amniotic fluid during pregnancy through ELISA.

Biochem/physiol Actions

Angiotensinogen acts as a precursor molecule in the renin-angiotensin-aldosterone system (RAAS) pathway. It is a part of the renin-angiotensin system that regulates blood pressure and fluid balance. Moreover, overactivation of the RAAS system has been associated with the development of several types of cancer, cardiovascular and renal diseases. Furthermore, in certain cancers angiotensin II has been shown to promote cancer metastasis.

Physical form

Lyophilized from 50 mM sodium phosphate, 150 mM NaCl, pH 7.0.

Preparation Note

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Please refer to vial label for lot-specific concentration prior to lyophilization.
Prepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.

Other Notes

Jeunemaitre, X., et al. 1992. Cell71, 169.
Tewksbury, D.A. 1983. Fed. Proc.42, 2724.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.
Toxicity: Standard Handling (A)


保管分類

11 - Combustible Solids

䞀䜓䜕が起きおいるの

WGK 3



最新バヌゞョンのいずれかを遞択しおください

詊隓成瞟曞COA

Lot/Batch Number

適切なバヌゞョンが芋぀かりたせんか。

特定のバヌゞョンが必芁な堎合は、ロット番号たたはバッチ番号で特定の蚌明曞を怜玢できたす。

以前この補品を賌入いただいたこずがある堎合

文曞ラむブラリで、最近賌入した補品の文曞を怜玢できたす。

文曞ラむブラリにアクセスする